Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: CA Cancer J Clin. 2017 Jul 6;67(5):411–431. doi: 10.3322/caac.21403
No clinically significant interaction expected
Potential interaction that may require a dosage adjustment, altered timing of administration, or additional monitoring
These drugs should not be co-administered
Not included in HEP Drug Interactions; however, metabolism and clearance data suggest that an interaction is unlikely
Not included in HEP Drug Interactions; however, metabolism and clearance data suggest that an interaction may occur